# CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
> **ANDA207455** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2018-04-11
## Drug
- **FDA Application Number:** ANDA207455
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
- **Generic name:** CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **Manufacturer:** Solco Healthcare LLC
- **First approval:** 2018-04-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207455)
---
*AI Analytics · CC0 1.0*